Plans In The Making To Vaccinate Every Pregnant Woman Against
Group B Streptococcus (GBS)
America's leading promoter of getting vaccinated and the H1N1 flu hype, the National Institute for Allergies and Infectious Diseases (NIAID) is developing a vaccine they say will prevent Group B Streptococcus (GBS) infections in newborns.
The Centers for Disease Control and Prevention (CDC) have been refining the myth for decades claiming that
GBS infections are the most common cause of meningitis in newborns. All women who are GBS positive are encouraged through conventional medicine to receive antibiotics, even though neonatal meningitis occurs in roughly 0.3 per 1000 live births making it very rare and less than 50% of all cases of bacterial meningitis have identified group B streptococci as the cause.
Although less than 30% of all women are colonized with GBS, the plan is to vaccine 100% of all pregnant women, a staggering percentage which will lead to unnecessarily vaccinating more than 70% of mothers to be.
The researchers, led by Sharon L. Hillier, Ph.D., from the Magee-Womens Research Institute at the University of the Pittsburgh, say they found that a vaccine can cause a modest but sustained reduction in genital and gastrointestinal GBS bacterial colonization.
Currently, one-third of pregnant women in the United States test positive for asymptomatic GBS and receive antibiotics during labor to prevent infection of the newborn. Although this antibiotic strategy is barely highly effective, helping saving 2 out of every 10,000 babies according to national statistics, the broad use of antibiotics in pregnant women continues and is of concern to public health officials.
The results of the study (randomized, double-blind controlled and sponsored by the NIAID) was only conducted on non-prenant women and had only a modest effect on bacterial colonization. The GBS vaccine was also stated to be safe and well-tolerated by women, however not one aspect of the study could conclude on the positive or negative health effects to newborns because none were studied. The next step by scientists is to develop vaccines for a broader range of GBS types.
An interesting fact that many pregnant women do not realize is that administration of antibiotics for GBS positive women is a relatively modern application by conventional medicine and did not exist more than a century ago. How were so many millions of babies born healthy without antibiotics? The statistics speak for themselves and the rates of infection for babies are very low and do not merit the risks of irresponsible antibiotic use and certainly not vaccines.
GBS is a normal intestinal bacteria and generally causes the human no problems. However, it is possible for the bacteria to migrate to the vaginal area of a pregnant woman. This would not make the woman sick, but does make it possible for the baby to come into contact with the bacteria while being born.
A recent Cochrane review calls into question this routine practice to every mother testing positive for GBS. Their research indicates that when mothers were treated with antibiotics when they tested positive, it did decrease the risk of early GBS infection, but there was no difference in either late onset GBS or with neonatal sepsis between the groups who received IV antibiotics and those who did not. Antibiotics given in labor also did not decrease the incidence of newborn death.
Researchers point out that even if a GBS vaccine is developed, all cases of GBS related infections are not likely to be prevented.
It is interesting to note that the researchers also suspect that the difference found in the early onset GBS was a result of bias in the studies that were a part of the review.
The downside to any treatment, whether is be vaccine or antibiotics to mother who are GBS positive is that it may cause other problems. One possible side effect is the potential for the mother to have an allergic reaction to the antibiotics. Not to mention, such early exposure of the baby to antibiotics can increase his or her problems with drug resistance later in life.
Another complication with antibiotic treatment is that it can cause mothers to develop yeast infections. Mothers and babies can then continue to pass persistent yeast infections back and forth through breastfeeding, known as thrush.
Any vaccine for GBS will only increase the likelyhood of heavy metals and preservative chemicals passing into the placenta and forcing the fetus to tolerate these toxins.
In summary, the Cochrane reviewers found that, based on the studies they analyzed "giving antibiotics is not supported by conclusive evidence" as a routine treatment for GBS.
This is important information to share with your care provider when discussing your own birth plan especially if your GBS test comes back positive.
Dave Mihalovic is a Naturopathic Doctor who specializes in vaccine research, cancer prevention and a natural approach to treatment.